Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Edwards Lifesciences Enters Into Accelerated Share Repurchase Agreement

Edwards Lifesciences Corporation
Posted on: 01 May 18
Edwards Lifesciences Enters Into Accelerated Share Repurchase Agreement

PR Newswire

IRVINE, Calif., May 1, 2018

IRVINE, Calif., May 1, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced today that it entered into an accelerated share repurchase (ASR) agreement to repurchase an aggregate of $400 million of Edwards' common stock.  Under the terms of this ASR agreement, Edwards will receive approximately 2.5 million shares in May 2018.  The final number of shares to be repurchased will be based on the volume weighted average share price during the term of the agreement. 

As of March 31, 2018, the company had approximately $1.3 billion authorization remaining on its share repurchase program approved by the Board of Directors. 

About Edwards Lifesciences
Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.  Driven by a passion to help patients, the company collaborates with the world's leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. For more information, visit and follow us on Twitter @EdwardsLifesci.

Edwards is a trademark of Edwards Lifesciences Corporation.  Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.


View original content with multimedia:

SOURCE Edwards Lifesciences Corporation

PR Newswire

Last updated on: 01/05/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.